Entries by merlin_admin

Erasmus MC present at Dutch Transplantation Society Meeting

Researchers from Merlin project partner Erasmus MC recently made a number of presentations at the Dutch Transplantation Society Meeting held on 9 and 10 March 2016 in Groningen. These included a poster presentation about the Merlin project entitled “Optimizing the immunogenicity and immunomodulatory properties of MSC “, (S.F.H. de Witte et al). For more details […]

3D Rendering from MSC Bio-distribution studies with BioInVision’s CryoViz cryo-imaging system

MERLIN is developing stem cell-based therapies that specifically target the inflammatory components of liver disease. Our partners BioInVision have developed a cryo-imaging system for 3D, microscopic imaging – the CryoViz instrument. CryoViz enables you to do cellular and molecular imaging where you get colour anatomy and exactly-registered multi-spectral molecular fluorescence. Check out our video, which shows […]

Prof. Antonella Viola publishes review on Mesenchymal stem cells: myths and reality

The group of Prof. Antonella Viola from University of Padua has recently published a review titled “Mesenchymal stem cells: myths and reality” in “Swiss Medical Weekly”, the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology and the Swiss Society of Rheumatology. In this review, they identified what […]


MERLIN will be presented in a bespoke session at EASL to highlight EU initiatives. An abstract we submitted to EASL has also been accepted as a parallel session oral presentation. The EASL 2016 Annual Meeting will be held in Barcelona 13-17 April 2016. EASL – The Home of Hepatology – is Europe’s preeminent liver association […]

MERLIN meeting in Birmingham 28-29 January

The MERLIN team met at the Radisson Blu Hotel, Birmingham 28 – 29 January 2016 to discuss the results of our pre-clinical work. We discussed preparations for the MERLIN clinical trial, including results from our MSC bio-distribution studies, pre-clinical experiments, and progress on the GMP manufacture of our stem cell therapy for PSC. We were joined by three […]

Report on EU MSC2 2015 meeting – Shaping the future of MSC Therapy

MERLIN researchers participated in the EU-MSC2 meeting in Leiden on the 7th and 8th of September 2015 The two-day meeting brought together researchers from nine EU-funded projects pursuing MSC research. In addition to REDDSTAR, other projects represented at the meeting included ADIPOA-2, REDDSTAR, VISICORT, Stellar, RETHRIM, REACH, MERLIN,SCIENCE and NEPHSTROM. After a welcome from Henri Lenferink, Mayor […]

EuroStemCell factsheets and exhibition

EuroStemCell recently came up with a new way to get the most out of a public event – they turned their fact sheets into an exhibition. From the content of the fact sheets with their quality, trustworthy and double-checked information, they created colourful posters about stem cells, stem cell research and diseases. And it worked! […]

Combating the rise of the silent killers – University of Birmingham article on tackling the deadly scourges of liver disease and diabetes

Coordinator Prof. Phil Newsome is featured in a new University of Birmingham article on tackling the twin deadly scourges of liver disease and diabetes. The article discusses how University of Birmingham researchers are spearheading efforts to tackle liver disease and diabetes; now recognised as two of the most serious global health epidemics, yet both ultimately […]

MERLIN Team Meeting in Padua 01 – 02 Oct

The MERLIN team met at the Venetian Institute of Molecular Medicine 01 – 02 October 2015 to discuss the results of our pre-clinical work, including work with MSC in vitro and in pre-clinical models of liver disease. Results from recent MSC bio-distribution studies were also presented. We discussed preparations for the MERLIN trial, including progress on the GMP manufacture of […]